You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
Wideband Tunable Multiferroic Electronics for Advanced RF Systems (1000-277)
SBC: SI2 TECHNOLOGIES, INC. Topic: ST13B003SI2 Technologies proposes to design, model, fabricate and transition wideband tunable multiferroic electronics for advanced RF systems including adaptive Radar, software defined radios and other electronic warfare (EW) applications. Combining novel nanost
STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency -
Multiferroic Materials for RF Applications
SBC: Winchester Technologies, LLC Topic: ST13B003Voltage tunable multiferroic materials with strong magnetoelectric coupling provide a unique approach to compact, lightweight and power efficient tunable RF/microwave multiferroic components, such as tunable inductors, filters, phase shifters, etc. The tu
STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency -
Low Control Voltage, Thin Film Multiferroic Tunable Devices for RF Applications
SBC: QUINSTAR TECHNOLOGY, INCORPORATED Topic: ST13B003We propose a novel suspended multiferroic thin film structure fabricated by semiconductor processing technologies as the basis for the approach to designing the multiferroic microstrip-based circuit elements such as tunable filters. The proposed approach
STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency -
A High-Level Operator Abstraction for GPU Graph Analytics
SBC: Royal Caliber Topic: ST13B004We propose to build a framework around an operator formulation to enable rapid development of massively parallel solutions to large graph problems. Graph algorithms are expressed by a small number of operators that are applied to components of the graph.
STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency -
New heterocyclic inhibitors of filoviruses
SBC: MICROBIOTIX, INC. Topic: HDESCRIPTION provided by applicant Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral i ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
New small molecule inhibitors of arenaviruses
SBC: MICROBIOTIX, INC. Topic: RDESCRIPTION provided by applicant Lassa fever virus LASV and Machupo virus MACV are hemorrhagic fever arenaviruses which are classified as Category A Agents Currently there are no licensed LASV or MACV vaccines and LASV MACV therapy is limited to use of the nucleoside analog ribavirin which is only partially effective and associated with significant side effects The impact of arenavirus ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens
SBC: SILVER LAKE RESEARCH CORPORATION Topic: NIAIDDESCRIPTION provided by applicant Bacterial resistance to lactam antibiotics is threatening to limit the effectiveness of this most used class of antibiotics A major contributin factor to this problem is the lack of rapid testing methods for medical practitioners to identify lactam resistant pathogens before prescribing specific antibiotics For urinary tract infections UTIs the most c ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
RAP as a therapeutic compound for neuronal regeneration after spinal cord injury
SBC: Novoron Bioscience Inc. Topic: 101DESCRIPTION provided by applicant RAP as a therapeutic compound for neuronal regeneration after spinal cord injury Novoron Bioscience Inc RESEARCH andamp RELATED Other Project Information Project Summary There are an estimated to new cases of spinal cord injury SCI each year and million people in the United States are paralyzed in some form due to SCI Currently ther ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of Peptide Antibiotic Nucleic Acids
SBC: NUBAD, LLC Topic: NIAIDDESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A molecularly targeted pre- and post-exposure vaccine for anthrax
SBC: VLP BIOTECH, INC. Topic: NIAIDDESCRIPTION provided by applicant We have shown that immunization of rabbits with multiple antigenic peptides MAPs displaying sequence from domain of protective antigen PA elicit antibodies specific for a linear determinant within the loop of PA that mediate potent neutralization of lethal toxin LeTx in vitro We have now shown in two separate large studies that antibodies aga ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health